0001437749-25-033041 | 10-Q | XBRL Viewer

Income Tax Disclosure [Text Block]

10. Income Taxes

The effective income tax rates were 24.7% and 26.1% for the three months ended September 30, 2025 and 2024, respectively. The effective income tax rates were 24.3% and 26.1% for the nine months ended September 30, 2025 and 2024, respectively.

For the three months ended September 30, 2025, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, partially offset by the use of federal employment tax credits and an excess tax benefit. For both the three months ended September 30, 2025 and 2024, the effective tax rates were inclusive of an excess tax benefit of 3.6% and 0.5%, respectively. The excess tax expense and tax benefit are discrete items, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

The entire disclosure for income tax.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets
Cash	$ 101,918	$ 98,911
Accounts receivable, net of allowances	134,050	122,880
Prepaid expenses and other current assets	24,693	38,591
Total current assets	260,661	260,382
Property and equipment, net of accumulated depreciation and amortization	24,444	24,703
Other assets
Goodwill	988,553	970,558
Intangibles, net of accumulated amortization	104,401	109,643
Operating lease assets, net	44,879	47,348
Total other assets	1,137,833	1,127,549
Total assets	1,422,938	1,412,634
Current liabilities
Accounts payable	16,677	27,176
Accrued payroll	74,131	62,053
Accrued expenses	32,942	28,959
Operating lease liabilities, current portion	13,031	12,800
Government stimulus advances	5,784	11,239
Accrued workers' compensation insurance	14,233	13,644
Total current liabilities	156,798	155,871
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs	150,640	218,443
Long-term operating lease liabilities	38,814	41,883
Deferred income tax	26,476	25,820
Other long-term liabilities	236	125
Total long-term liabilities	216,166	286,271
Total liabilities	372,964	442,142
Stockholders' equity
Common stock—$.001 par value; 40,000 authorized and 18,483 and 18,148 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	18	18
Additional paid-in capital	607,398	594,044
Retained earnings	442,558	376,430
Total stockholders' equity	1,049,974	970,492
Total liabilities and stockholders' equity	$ 1,422,938	$ 1,412,634

Note 9 - Long-Term Debt (Details Textual) $ in Thousands		9 Months Ended
Note 9 - Long-Term Debt (Details Textual) $ in Thousands	Oct. 22, 2024 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)	Jun. 30, 2025 USD ($)	Dec. 31, 2024 USD ($)
Proceeds from Lines of Credit		$ 11,335	$ 0
Repayments of Lines of Credit		80,000	$ 126,353
Credit Agreement [Member]
Debt Instrument, Face Amount	$ 150,000
Debt Instrument, Maturity Date	Jul. 30, 2028
Credit Agreement [Member] \| Minimum [Member]
Debt Instrument, Interest Rate, Effective Percentage	0.00%
Credit Agreement [Member] \| Minimum [Member] \| Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.75%
Credit Agreement [Member] \| Maximum [Member] \| Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate	2.50%
Revolving Credit Facility [Member] \| Credit Agreement [Member]
Long-Term Line of Credit		650,000
Line of Credit Facility, Remaining Borrowing Capacity		487,700
Capital One, National Association [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 650,000
Line of Credit, Net Leverage Ratio	3.75	4.25
Debt Instrument, Covenant, Maximus Distribution Amount				$ 10,000
Proceeds from Lines of Credit		$ 11,300
Repayments of Lines of Credit		80,000
Long-Term Line of Credit		$ 154,300			$ 223,000
Debt Instrument, Interest Rate, Stated Percentage		5.92%			6.34%
Lines of Credit, Outstanding Limits		$ 7,900
Capital One, National Association [Member] \| Revolving Credit Facility [Member] \| Federal Funds Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Capital One, National Association [Member] \| Revolving Credit Facility [Member] \| Minimum [Member]
Debt Instrument, Interest Rate, Effective Percentage	0.00%
Debt Instrument, Leverage Ratio Fee, Percent	0.20%
Capital One, National Association [Member] \| Revolving Credit Facility [Member] \| Minimum [Member] \| Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	0.75%
Capital One, National Association [Member] \| Revolving Credit Facility [Member] \| Maximum [Member]
Debt Instrument, Leverage Ratio Fee, Percent	0.35%
Capital One, National Association [Member] \| Revolving Credit Facility [Member] \| Maximum [Member] \| Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	1.50%
Capital One, National Association [Member] \| Revolving Credit Facility [Member] \| Weighted Average [Member] \| Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Interest Rate, Effective Percentage	1.00%

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares shares in Thousands	Sep. 30, 2025	Dec. 31, 2024
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	40,000	40,000
Common stock, shares issued (in shares)	18,483	18,148
Common stock, shares outstanding (in shares)	18,483	18,148

Note 7 - Details of Certain Balance Sheet Accounts (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Other Current Assets [Table Text Block]

	*September 30, 2025*		*December 31, 2024*
	(Amounts in Thousands)
Income tax receivable	$	2,255	$	11,568
Prepaid payroll		5,506		8,716
Prepaid workers' compensation and liability insurance		5,323		4,254
Prepaid licensing fees		4,874		5,414
Workers' compensation insurance receivable		804		810
Other ⁽¹⁾		5,931		7,829
Total prepaid expenses and other current assets	$	24,693	$	38,591

Schedule of Accrued Liabilities [Table Text Block]

	*September 30, 2025*		*December 31, 2024*
	(Amounts in Thousands)
Accrued health benefits	$	6,602	$	6,637
Accrued professional fees		6,151		5,368
Accrued payroll and other taxes		5,681		4,516
Other		14,508		12,438
Total accrued expenses	$	32,942	$	28,959

Note 4 - Leases - Schedule Of Balance Sheet Information, Related To Operating Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Operating lease assets, net	$ 44,879	$ 47,348
Short-term operating lease liabilities	13,031	12,800
Long-term operating lease liabilities	38,814	41,883
Total operating lease liabilities	$ 51,845	$ 54,683

Note 13 - Significant Payors (Details Textual) - ILLINOIS	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Geographic Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Concentration Risk, Percentage	32.00%	38.60%	32.60%	38.50%
Customer Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Concentration Risk, Percentage	18.10%	21.40%	18.40%	21.10%
Customer Concentration Risk [Member] \| Accounts Receivable [Member]
Concentration Risk, Percentage			16.60%		21.70%

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References + Details

Note 5 - Acquisition - Unaudited Pro Forma Consolidated Income Statement Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Net service revenues	$ 364,001	$ 293,804	$ 1,060,396	$ 868,481
Operating income	32,153	26,486	97,372	76,915
Net income	$ 22,327	$ 20,555	$ 67,120	$ 54,908
Basic income per share (in dollars per share)	$ 1.24	$ 1.15	$ 3.72	$ 3.29
Diluted income per share (in dollars per share)	$ 1.21	$ 1.13	$ 3.65	$ 3.22

Note 4 - Leases

9 Months Ended

Sep. 30, 2025

Lessee, Operating Leases [Text Block]

4. Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

	*September 30, 2025*		*December 31, 2024*
	(Amounts in Thousands)
Operating lease assets, net	$	44,879	$	47,348

Short-term operating lease liabilities		13,031		12,800
Long-term operating lease liabilities		38,814		41,883
Total operating lease liabilities	$	51,845	$	54,683

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	*For the Three Months Ended September 30,*					*For the Nine Months Ended September 30,*
	(Amounts in Thousands)					(Amounts in Thousands)
	*2025*		*2024*			*2025*			*2024*
Operating lease costs	$	3,623	$	3,393		$	10,931		$	10,062
Short-term lease costs		292		167			847			547
Total lease costs		3,915		3,560			11,778			10,609
Less: sublease income		—		(596	)		(226	)		(1,685	)
Total lease costs, net	$	3,915	$	2,964		$	11,552		$	8,924

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

	*September 30, 2025*			*December 31, 2024*
Operating leases:
Weighted average remaining lease term		5.22			5.48
Weighted average discount rate		6.37	%		6.20	%

Maturity of Lease Liabilities

Remaining operating lease payments as of September 30, 2025 were as follows:

	*Operating Leases*
	(Amounts in Thousands)
Due in the 12-month period ended September 30,
2026	$	15,759
2027		12,614
2028		9,143
2029		6,946
2030		6,016
Thereafter		11,064
Total future minimum rental commitments		61,542
Less: Imputed interest		(9,697	)
Total lease liabilities	$	51,845

Supplemental Cash Flows Information

	*For the Nine Months Ended September 30,*
	(Amounts in Thousands)
	*2025*		*2024*
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	12,505	$	10,925

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	7,156	$	7,683

Note 2 - Summary of Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Basic (in shares)	18,072	17,868	18,031	16,707
Diluted (in shares)	18,390	18,255	18,365	17,065
Share-Based Payment Arrangement, Option [Member]
Stock options (in shares)	210	278	217	254
Stock options, Anti-dilutive (in shares)	0	0	0	0
Restricted Stock [Member]
Stock options (in shares)	108	109	117	104
Stock options, Anti-dilutive (in shares)	0	0	0	0

Note 13 - Significant Payors

9 Months Ended

Sep. 30, 2025

Concentration Risk Disclosure [Text Block]

13. Significant Payors

The Company’s revenue by payor type was as follows:

*Personal Care Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
State, local and other governmental programs	$	139,383		50.5	%	$	116,702		54.2	%	$	410,781		51.1	%	$	337,458		53.0	%
Managed care organizations		127,293		46.2			93,321		43.3			366,210		45.6			281,732		44.3
Private pay		7,064		2.5			3,599		1.7			21,331		2.7			11,194		1.8
Commercial insurance		1,860		0.7			1,415		0.7			4,356		0.5			4,368		0.7
Other		170		0.1			396		0.1			560		0.1			1,501		0.2
Total personal care segment net service revenues	$	275,770		100.0	%	$	215,433		100.0	%	$	803,238		100.0	%	$	636,253		100.0	%

*Hospice Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Medicare	$	64,148		93.1	%	$	52,413		91.5	%	$	178,784		92.9	%	$	154,187		91.1	%
Commercial insurance		2,140		3.1			2,892		5.0			6,518		3.4			8,870		5.2
Managed care organizations		2,216		3.2			1,821		3.2			6,245		3.2			5,518		3.3
Other		387		0.6			183		0.3			993		0.5			627		0.4
Total hospice segment net service revenues	$	68,891		100.0	%	$	57,309		100.0	%	$	192,540		100.0	%	$	169,202		100.0	%

*Home Health Segment*	*For the Three Months Ended September 30,*											*For the Nine Months Ended September 30,*
	*2025*					*2024*						*2025*					*2024*
			*% of Segment*						*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*			*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*			*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Medicare	$	11,617		65.9	%	$	12,036			70.6	%	$	36,711		68.4	%	$	36,216		69.6	%
Managed care organizations		4,492		25.5			4,215			24.7			12,564		23.4			13,291		25.6
State, local and other governmental programs (excluding Medicare)		993		5.6			(17	)		—			2,878		5.3			—		—
Other		538		3.0			811			4.7			1,521		2.9			2,493		4.8
Total home health segment net service revenues	$	17,640		100.0	%	$	17,045			100.0	%	$	53,674		100.0	%	$	52,000		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states and New York for the three and nine months ended September 30, 2025 and 2024, respectively, were as follows:

*Personal Care Segment*	*For the Three Months Ended September 30,*											*For the Nine Months Ended September 30,*
	*2025*						*2024*					*2025*						*2024*
				*% of Segment*					*% of Segment*						*% of Segment*					*% of Segment*
	*Amount*			*Net Service*			*Amount*		*Net Service*			*Amount*			*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*			*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*			*Revenues*			*(in Thousands)*		*Revenues*
Illinois	$	115,989			42.1	%	$	111,916		51.9	%	$	342,629			42.7	%	$	330,265		51.9	%
New Mexico		30,029			10.9			28,962		13.4			87,320			10.9			86,573		13.6
New York⁽¹⁾		(318	)		—			21,406		9.9			(104	)		—			68,239		10.7
Texas		53,449			19.4			—		—			155,773			19.4			—		—
All other states		76,621			27.6			53,149		24.8			217,620			27.0			151,176		23.8
Total personal care segment net service revenues	$	275,770			100.0	%	$	215,433		100.0	%	$	803,238			100.0	%	$	636,253		100.0	%

(1)

As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

*Hospice Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Ohio	$	26,913		39.1	%	$	21,531		37.6	%	$	73,304		38.1	%	$	62,400		36.9	%
Illinois		15,532		22.5			13,289		23.2			44,516		23.1			38,544		22.8
New Mexico		8,769		12.7			6,951		12.1			24,865		12.9			21,361		12.6
All other states		17,677		25.7			15,538		27.1			49,855		25.9			46,897		27.7
Total hospice segment net service revenues	$	68,891		100.0	%	$	57,309		100.0	%	$	192,540		100.0	%	$	169,202		100.0	%

*Home Health Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
New Mexico	$	8,644		49.0	%	$	8,090		47.4	%	$	25,937		48.3	%	$	24,166		46.5	%
Tennessee		6,852		38.8			6,542		38.4			21,672		40.4			19,437		37.4
Illinois		1,759		10.0			2,413		14.2			5,680		10.6			8,397		16.1
All other states		385		2.2			—		—			385		0.7			—		—
Total home health segment net service revenues	$	17,640		100.0	%	$	17,045		100.0	%	$	53,674		100.0	%	$	52,000		100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 32.0% and 38.6% of our net service revenues for the three months ended September 30, 2025 and 2024, respectively, and accounted for 32.6% and 38.5% of our net service revenues for the nine months ended September 30, 2025 and 2024, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 18.1% and 21.4% of the Company’s net service revenues for the three months ended September 30, 2025 and 2024, respectively, and accounted for 18.4% and 21.1% of the Company’s net service revenues for the nine months ended September 30, 2025 and 2024, respectively.

The related receivables due from the Illinois Department on Aging represented 16.6% and 21.7% of the Company’s net accounts receivable at September 30, 2025 and December 31, 2024, respectively.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (d)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/275/tableOfContent

Note 11 - Commitments and Contingencies

9 Months Ended

Sep. 30, 2025

Commitments and Contingencies Disclosure [Text Block]

11. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

Note 12 - Segment Information (Details Textual)	9 Months Ended
Note 12 - Segment Information (Details Textual)	Sep. 30, 2025
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]	Chief Executive Officer [Member]
Number of Operating Segments	3
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description	The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

Note 8 - ARPA Spending Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2025	Dec. 31, 2024
Government Assistance, Liability, Current	$ 5,784	$ 5,784	$ 11,239
ARPA Spending Plans [Member]
Government Assistance, Liability, Increase, Current	0	0
Government Assistance, Operating Expense, Decrease (Increase)	2,200	5,500
Government Assistance, Liability, Current	$ 5,800	$ 5,800

Note 4 - Leases - Lease Term and Discount Rate (Details)	Sep. 30, 2025	Dec. 31, 2024
Weighted average remaining lease term (Year)	5 years 2 months 19 days	5 years 5 months 23 days
Weighted average discount rate	6.37%	6.20%

Note 6 - Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands				3 Months Ended		9 Months Ended
	Aug. 01, 2025	Mar. 01, 2025	Jan. 01, 2025	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Mar. 31, 2025	Dec. 31, 2024
Goodwill				$ 988,553		$ 988,553			$ 970,558
Goodwill, Measurement Period Adjustment				(300)		(4,412)
Proceeds from Previous Acquisition						2,937	$ 0
Amortization of Intangible Assets				$ 2,400	$ 1,800	$ 6,400	$ 5,400
Finite-Lived Intangible Assets, Remaining Amortization Period (Year)				9 years 3 months 10 days		9 years 3 months 10 days
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)				1 year		1 year
Minimum [Member] \| Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)				3 years		3 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)				20 years		20 years
Maximum [Member] \| Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)				15 years		15 years
Personal Care Segment [Member]
Goodwill				$ 460,837		$ 460,837			$ 442,526
Goodwill, Measurement Period Adjustment						(4,096)
Jacksonville Affiliate [Member]
Business Combination, Consideration Transferred			$ 800
Jacksonville Affiliate [Member] \| Personal Care Segment [Member]
Goodwill			$ 800
Great Lakes Home Care Unlimited, LLC [Member]
Business Combination, Consideration Transferred		$ 2,600
Great Lakes Home Care Unlimited, LLC [Member] \| Personal Care Segment [Member]
Goodwill								$ 2,600
Helping Hands Home Care Service, Inc. [Member]
Business Combination, Consideration Transferred	$ 21,400
Goodwill	19,022
Helping Hands Home Care Service, Inc. [Member] \| State Licenses [Member]
Finite-Lived Intangible Assets Acquired	$ 1,200
Helping Hands Home Care Service, Inc. [Member] \| Personal Care Segment [Member]
Goodwill				$ 19,100		19,100
Helping Hands Home Care Service, Inc. [Member] \| Personal Care Segment [Member] \| State Licenses [Member]
Finite-Lived Intangible Assets Acquired						1,200
Gentiva Acquisition [Member]
Proceeds from Previous Acquisition						$ 2,900

Note 4 - Leases - Schedule of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Operating lease costs	$ 3,623	$ 3,393	$ 10,931	$ 10,062
Short-term lease costs	292	167	847	547
Total lease costs	3,915	3,560	11,778	10,609
Less: sublease income	0	(596)	(226)	(1,685)
Total lease costs, net	$ 3,915	$ 2,964	$ 11,552	$ 8,924

Note 13 - Significant Payors (Tables)

9 Months Ended

Sep. 30, 2025

Revenue from External Customers by Products and Services [Table Text Block]

*Personal Care Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
State, local and other governmental programs	$	139,383		50.5	%	$	116,702		54.2	%	$	410,781		51.1	%	$	337,458		53.0	%
Managed care organizations		127,293		46.2			93,321		43.3			366,210		45.6			281,732		44.3
Private pay		7,064		2.5			3,599		1.7			21,331		2.7			11,194		1.8
Commercial insurance		1,860		0.7			1,415		0.7			4,356		0.5			4,368		0.7
Other		170		0.1			396		0.1			560		0.1			1,501		0.2
Total personal care segment net service revenues	$	275,770		100.0	%	$	215,433		100.0	%	$	803,238		100.0	%	$	636,253		100.0	%

*Hospice Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Medicare	$	64,148		93.1	%	$	52,413		91.5	%	$	178,784		92.9	%	$	154,187		91.1	%
Commercial insurance		2,140		3.1			2,892		5.0			6,518		3.4			8,870		5.2
Managed care organizations		2,216		3.2			1,821		3.2			6,245		3.2			5,518		3.3
Other		387		0.6			183		0.3			993		0.5			627		0.4
Total hospice segment net service revenues	$	68,891		100.0	%	$	57,309		100.0	%	$	192,540		100.0	%	$	169,202		100.0	%

*Home Health Segment*	*For the Three Months Ended September 30,*											*For the Nine Months Ended September 30,*
	*2025*					*2024*						*2025*					*2024*
			*% of Segment*						*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*			*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*			*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Medicare	$	11,617		65.9	%	$	12,036			70.6	%	$	36,711		68.4	%	$	36,216		69.6	%
Managed care organizations		4,492		25.5			4,215			24.7			12,564		23.4			13,291		25.6
State, local and other governmental programs (excluding Medicare)		993		5.6			(17	)		—			2,878		5.3			—		—
Other		538		3.0			811			4.7			1,521		2.9			2,493		4.8
Total home health segment net service revenues	$	17,640		100.0	%	$	17,045			100.0	%	$	53,674		100.0	%	$	52,000		100.0	%

*Personal Care Segment*	*For the Three Months Ended September 30,*											*For the Nine Months Ended September 30,*
	*2025*						*2024*					*2025*						*2024*
				*% of Segment*					*% of Segment*						*% of Segment*					*% of Segment*
	*Amount*			*Net Service*			*Amount*		*Net Service*			*Amount*			*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*			*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*			*Revenues*			*(in Thousands)*		*Revenues*
Illinois	$	115,989			42.1	%	$	111,916		51.9	%	$	342,629			42.7	%	$	330,265		51.9	%
New Mexico		30,029			10.9			28,962		13.4			87,320			10.9			86,573		13.6
New York⁽¹⁾		(318	)		—			21,406		9.9			(104	)		—			68,239		10.7
Texas		53,449			19.4			—		—			155,773			19.4			—		—
All other states		76,621			27.6			53,149		24.8			217,620			27.0			151,176		23.8
Total personal care segment net service revenues	$	275,770			100.0	%	$	215,433		100.0	%	$	803,238			100.0	%	$	636,253		100.0	%

*Hospice Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
Ohio	$	26,913		39.1	%	$	21,531		37.6	%	$	73,304		38.1	%	$	62,400		36.9	%
Illinois		15,532		22.5			13,289		23.2			44,516		23.1			38,544		22.8
New Mexico		8,769		12.7			6,951		12.1			24,865		12.9			21,361		12.6
All other states		17,677		25.7			15,538		27.1			49,855		25.9			46,897		27.7
Total hospice segment net service revenues	$	68,891		100.0	%	$	57,309		100.0	%	$	192,540		100.0	%	$	169,202		100.0	%

*Home Health Segment*	*For the Three Months Ended September 30,*										*For the Nine Months Ended September 30,*
	*2025*					*2024*					*2025*					*2024*
			*% of Segment*					*% of Segment*					*% of Segment*					*% of Segment*
	*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*			*Amount*		*Net Service*
	*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*			*(in Thousands)*		*Revenues*
New Mexico	$	8,644		49.0	%	$	8,090		47.4	%	$	25,937		48.3	%	$	24,166		46.5	%
Tennessee		6,852		38.8			6,542		38.4			21,672		40.4			19,437		37.4
Illinois		1,759		10.0			2,413		14.2			5,680		10.6			8,397		16.1
All other states		385		2.2			—		—			385		0.7			—		—
Total home health segment net service revenues	$	17,640		100.0	%	$	17,045		100.0	%	$	53,674		100.0	%	$	52,000		100.0	%

Note 9 - Long-Term Debt - Schedule of Debt Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Less unamortized issuance costs	$ (3,695)	$ (4,557)
Long-term debt	150,640	218,443
Capital One, National Association [Member] \| Revolving Credit Facility [Member]
Revolving loan under the credit facility	$ 154,335	$ 223,000

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income	$ 66,128	$ 54,072
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization	12,264	10,316
Deferred income taxes	656	188
Stock-based compensation	11,877	8,307
Amortization of debt issuance costs under the credit facility	967	644
Provision for credit losses	1,048	812
Gain on disposal of assets	(6)	(13)
Loss on termination of operating leases	23	9
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(8,513)	17,868
Prepaid expenses and other current assets	9,848	6,187
Government stimulus advances	(5,455)	7,890
Accounts payable	(12,204)	1,003
Accrued payroll	11,439	1,431
Accrued expenses and other long-term liabilities	4,672	(2,698)
Net cash provided by operating activities	92,744	106,016
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(24,181)	(400)
Purchases of property and equipment	(5,056)	(4,353)
Proceeds received from disposal of assets	8	29
Proceeds received from previous acquisition	2,937	0
Proceeds received from divestiture of business	3,848	4,600
Net cash used in investing activities	(22,444)	(124)
Cash flows from financing activities:
Payments on revolver — credit facility	(80,000)	(126,353)
Proceeds from borrowings on revolver — credit facility	11,335	0
Payments for debt issuance costs under the credit facility	(105)	(39)
Proceeds from Public offering	0	175,578
Cash received from exercise of stock options	1,477	2,983
Net cash (used in) provided by financing activities	(67,293)	52,169
Net change in cash	3,007	158,061
Cash, at beginning of period	98,911	64,791
Cash, at end of period	101,918	222,852
Supplemental disclosures of cash flow information:
Cash paid for interest	10,071	4,801
Cash paid for income taxes	$ 9,240	$ 19,436

Note 2 - Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2025

Significant Accounting Policies [Text Block]

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

	*For the Three Months Ended September 30,*				*For the Nine Months Ended September 30,*
	(Amounts in thousands)				(Amounts in thousands)
	*2025*		*2024*		*2025*		*2024*
Weighted average number of shares outstanding for basic per share calculation		18,072		17,868		18,031		16,707
Effect of dilutive potential shares:
Stock options		210		278		217		254
Restricted stock awards		108		109		117		104
Adjusted weighted average shares for diluted per share calculation		18,390		18,255		18,365		17,065
Anti-dilutive shares:
Stock options		—		—		—		—
Restricted stock awards		—		—		—		—

Recently Adopted Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity’s chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU was adopted in connection with the Company's most recent Annual Report on Form 10-K, which included significant segment expenses reviewed by the Company’s CODM, but did not have a material impact on the Company’s results of operations, financial position, or cash flows.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied on a prospective basis with the option to apply the standard retrospectively, and allows for early adoption. These requirements are not expected to have a material impact on the Company’s financial statements and will expand income tax disclosures.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

In July 2025, the FASB issued ASU 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which replaces the incurred-loss model with a forward-looking current expected credit loss model that requires recognition of lifetime expected credit losses on financial assets measured at amortized cost and certain off-balance-sheet credit exposures (including trade accounts receivable and contract assets), using historical experience, current conditions, and reasonable and supportable forecasts. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The disclosure updates should be applied prospectively. The Company is currently assessing the impact and timing of adopting the updated provisions.

Note 9 - Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Long-Term Debt Instruments [Table Text Block]

	*September 30, 2025*			*December 31, 2024*
	(Amounts in Thousands)
Revolving loan under the credit facility	$	154,335		$	223,000
Less unamortized issuance costs		(3,695	)		(4,557	)
Long-term debt	$	150,640		$	218,443

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477734/942-470-50-3

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

Note 3 - Divestiture (Details Textual) - USD ($) $ in Thousands		1 Months Ended	9 Months Ended		12 Months Ended
	May 20, 2024	Oct. 31, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Proceeds from Divestiture of Businesses			$ 3,848	$ 4,600
New York Asset Sale [Member]
Disposal Group, Including Discontinued Operation, Consideration	$ 23,000
Disposal Group, Including Discontinued Operation, Cash Consideration, Percent	50.00%
Proceeds from Divestiture of Businesses	$ 4,600
Disposal Group, Including Discontinued Operation, Consideration Receivable Debt	$ 6,900		2,300
Disposal Group, Including Discontinued Operation, Contingent Consideration, Percent	50.00%
Divesture of Businesses, Consideration Transferred, Percentage		50.00%
Gain (Loss) on Disposition of Business					$ 3,700
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent			2,900
Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent			4,200
New York Asset Sale [Member] \| Deferred Payments [Member]
Proceeds from Divestiture of Businesses			$ 3,800

Insider Trading Arrangements

3 Months Ended

9 Months Ended

Sep. 30, 2025

Material Terms of Trading Arrangement [Text Block]

Item 5. Other Information

During the quarter ended September 30, 2025, each of the following directors and Section 16 officers terminated a Rule 10b5-1 Trading Arrangement (as defined in Item 408(a) of Regulation S-K) to sell common shares:

Shares Vesting and Subject to

Other Shares Being Sold

Name

Title

Adoption Date

Expiration Date (1)

Termination Date

Sell-To-Cover (2)

(Subject to Certain Conditions)

W. Bradley Bickham

President and Chief Operating Officer

March 5, 2025

February 24, 2026

August 13, 2025

12,173

n/a

(1) Each plan would have expired on the date represented in the table or upon the earlier completion of all transactions contemplated by the arrangement.

(2) This column indicates the total number of shares vesting in connection with equity awards, not the number of shares to be sold. The actual number of shares to be sold would have been a smaller number based on whatever was required to satisfy payment of applicable withholding taxes under sell-to-cover arrangements.

During the quarter ended September 30, 2025, each of the following directors and Section 16 officers adopted a Rule 10b5-1 Trading Arrangement (as defined in Item 408(a) of Regulation S-K) to sell common shares:

				Shares Vesting and Subject to		Other Shares Being Sold
Name	Title	Adoption Date	Expiration Date (1)	Sell-To-Cover (2)		(Subject to Certain Conditions)
W. Bradley Bickham	President and Chief Operating Officer	August 13, 2025	March 10, 2026		26,760		n/a
W. Bradley Bickham	President and Chief Operating Officer	September 5, 2025	March 26, 2026		36,161		n/a

(1) Each plan will expire on the date represented in the table or upon the earlier completion of all transactions contemplated by the arrangement.

(2) This column indicates the total number of shares vesting in connection with equity awards, not the number of shares to be sold. The actual number of shares to be sold will be a smaller number based on whatever is required to satisfy payment of applicable withholding taxes under sell-to-cover arrangements.

Non-Rule 10b5-1 Arrangement Terminated [Flag]

false

Non-Rule 10b5-1 Arrangement Adopted [Flag]

false

W. Bradley Bickham [Member]

Rule 10b5-1 Arrangement Terminated [Flag]

true

Trading Arrangement, Individual Name

W. Bradley Bickham

Trading Arrangement, Individual Title

President and Chief Operating Officer

Trading Arrangement Expiration Date

February 24, 2026

Trading Arrangement Termination Date

August 13, 2025

Trading Arrangement, Securities Aggregate Available Amount

12,173

W. Bradley Bickham 2 [Member]

Trading Arrangement, Individual Name

W. Bradley Bickham

Trading Arrangement, Individual Title

President and Chief Operating Officer

Trading Arrangement Expiration Date

March 10, 2026

Trading Arrangement, Securities Aggregate Available Amount

26,760

Rule 10b5-1 Arrangement Adopted [Flag]

true

Trading Arrangement Adoption Date

August 13, 2025

W. Bradley Bickham 3 [Member]

Trading Arrangement, Individual Name

W. Bradley Bickham

Trading Arrangement, Individual Title

President and Chief Operating Officer

Trading Arrangement Expiration Date

March 26, 2026

Trading Arrangement, Securities Aggregate Available Amount

36,161

Rule 10b5-1 Arrangement Adopted [Flag]

true

Trading Arrangement Adoption Date

September 5, 2025

Note 14 - Subsequent Events (Details Textual) $ in Millions	Oct. 01, 2025 USD ($)
Gold Horses, LLC [Member] \| Subsequent Event [Member]
Business Combination, Consideration Transferred	$ 7.4

Note 9 - Long-Term Debt

9 Months Ended

Sep. 30, 2025

Long-Term Debt [Text Block]

9. Long-Term Debt

Long-term debt consisted of the following:

	*September 30, 2025*			*December 31, 2024*
	(Amounts in Thousands)
Revolving loan under the credit facility	$	154,335		$	223,000
Less unamortized issuance costs		(3,695	)		(4,557	)
Long-term debt	$	150,640		$	218,443

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023, and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of October 22, 2024 (as described below, the “Fourth Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2028.

On October 22, 2024, the Company entered into the Fourth Amendment to, among other things, (a) increase the Company’s revolving credit facility to an aggregate amount of $650.0 million, (b) increase the Company’s incremental loan facility to an aggregate amount of $150.0 million, and (c) extend the maturity date of the credit facility from July 30, 2026 to July 30, 2028.

Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50%, and (c) the sum of Term Secured Overnight Financing Rate (“SOFR”) (as published by the CME Group Benchmark Administrative Limited) for an interest period of one month for such applicable day (not to be less than 0.00%), plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period (not to be less than 0.00%). Swing loans may not be SOFR loans.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property, and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments, and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $10.0 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

During the nine months ended September 30, 2025, the Company (i) drew approximately $11.3 million under its credit facility to fund, in part, the Helping Hands Acquisition, and (ii) repaid $80.0 million under the revolving credit facility.

As of September 30, 2025, the Company had a total of $154.3 million of revolving loans, with an interest rate of 5.92%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $7.9 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $650.0 million of capacity and $487.7 million available for borrowing under its credit facility. As of December 31, 2024, the Company had a total of $223.0 million of revolving loans, with an interest rate of 6.34%, outstanding on its credit facility.

As of September 30, 2025, the Company was in compliance with all financial covenants under the Credit Agreement.

Note 4 - Leases (Tables)

9 Months Ended

Sep. 30, 2025

Schedule Of Balance Sheet Information, Related To Operating Leases [Table Text Block]

	*September 30, 2025*		*December 31, 2024*
	(Amounts in Thousands)
Operating lease assets, net	$	44,879	$	47,348

Short-term operating lease liabilities		13,031		12,800
Long-term operating lease liabilities		38,814		41,883
Total operating lease liabilities	$	51,845	$	54,683

Lease, Cost [Table Text Block]

	*For the Three Months Ended September 30,*					*For the Nine Months Ended September 30,*
	(Amounts in Thousands)					(Amounts in Thousands)
	*2025*		*2024*			*2025*			*2024*
Operating lease costs	$	3,623	$	3,393		$	10,931		$	10,062
Short-term lease costs		292		167			847			547
Total lease costs		3,915		3,560			11,778			10,609
Less: sublease income		—		(596	)		(226	)		(1,685	)
Total lease costs, net	$	3,915	$	2,964		$	11,552		$	8,924

Schedule of Lease Term and Discount Rate [Table Text Block]

	*September 30, 2025*			*December 31, 2024*
Operating leases:
Weighted average remaining lease term		5.22			5.48
Weighted average discount rate		6.37	%		6.20	%

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

	*Operating Leases*
	(Amounts in Thousands)
Due in the 12-month period ended September 30,
2026	$	15,759
2027		12,614
2028		9,143
2029		6,946
2030		6,016
Thereafter		11,064
Total future minimum rental commitments		61,542
Less: Imputed interest		(9,697	)
Total lease liabilities	$	51,845

Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]

	*For the Nine Months Ended September 30,*
	(Amounts in Thousands)
	*2025*		*2024*
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	12,505	$	10,925

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	7,156	$	7,683

Note 5 - Acquisition - Schedule of Fair Values of Assets and Liabilities Acquired (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Aug. 01, 2025	Dec. 31, 2024
Goodwill	$ 988,553		$ 970,558
Helping Hands Home Care Service, Inc. [Member]
Goodwill		$ 19,022
Identifiable intangible assets		1,150
Cash		584
Accounts receivable		1,365
Property and equipment		19
Operating lease assets, net		282
Other current assets		45
Accounts payable		(98)
Accrued payroll		(697)
Operating lease liabilities, total		(257)
Total purchase price		$ 21,415

Note 5 - Acquisitions (Tables)

9 Months Ended

Sep. 30, 2025

Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]

	*Total (Amounts in Thousands)*
Goodwill	$	19,022
Identifiable intangible assets		1,150
Cash		584
Accounts receivable		1,365
Property and equipment		19
Operating lease assets, net		282
Other current assets		45
Accounts payable		(98	)
Accrued payroll		(697	)
Operating lease liabilities, total		(257	)
Total purchase price	$	21,415

Business Combination, Pro Forma Information [Table Text Block]

	*For the Three Months Ended September 30,*				*For the Nine Months Ended September 30,*
	(Amounts in Thousands)				(Amounts in thousands)
	*2025*		*2024*		*2025*		*2024*
Net service revenues	$	364,001	$	293,804	$	1,060,396	$	868,481
Operating income		32,153		26,486		97,372		76,915
Net income		22,327		20,555		67,120		54,908
Net income per common share
Basic income per share	$	1.24	$	1.15	$	3.72	$	3.29
Diluted income per share	$	1.21	$	1.13	$	3.65	$	3.22

Note 7 - Details of Certain Balance Sheet Accounts (Details Textual) - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
New York Asset Sale [Member]
Disposal Group, Including Discontinued Operation, Consideration Receivable Debt	$ 2.3	$ 6.1

Note 12 - Segment Information (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	*For the Three Months Ended September 30, 2025*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	275,770	$	68,891	$	17,640	$	362,301
Direct service personnel		199,656		28,287		10,155		238,098
General and administrative salaries, wages and benefits		18,629		11,658		3,538		33,825
Other segment items ¹		6,395		10,131		1,400		17,926
Segment operating income		51,090		18,815		2,547		72,452
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								35,107
Depreciation and amortization								4,408
Interest income								(760	)
Interest expense								3,343
Income before income taxes							$	30,354

	*For the Three Months Ended September 30, 2024*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	215,433	$	57,309	$	17,045	$	289,787
Direct service personnel		156,072		24,791		10,513		191,376
General and administrative salaries, wages and benefits		11,949		10,556		3,553		26,058
Other segment items ¹		5,741		9,192		1,113		16,046
Segment operating income		41,671		12,770		1,866		56,307
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								26,908
Depreciation and amortization								3,446
Interest income								(1,908	)
Interest expense								573
Income before income taxes							$	27,288

	*For the Nine Months Ended September 30, 2025*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	803,238	$	192,540	$	53,674	$	1,049,452
Direct service personnel		579,174		80,670		30,019		689,863
General and administrative salaries, wages and benefits		55,276		34,085		9,846		99,207
Other segment items ¹		18,468		29,531		3,866		51,865
Segment operating income		150,320		48,254		9,943		208,517
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								99,915
Depreciation and amortization								12,264
Interest income								(1,845	)
Interest expense								10,886
Income before income taxes							$	87,297

	*For the Nine Months Ended September 30, 2024*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	636,253	$	169,202	$	52,000	$	857,455
Direct service personnel		460,587		71,580		31,967		564,134
General and administrative salaries, wages and benefits		35,049		30,601		10,893		76,543
Other segment items ¹		15,835		27,960		3,773		47,568
Segment operating income		124,782		39,061		5,367		169,210
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								83,115
Depreciation and amortization								10,316
Interest income								(2,805	)
Interest expense								5,445
Income before income taxes							$	73,139

Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2025

Accounting Policies [Abstract]

Use of Estimates, Policy [Policy Text Block]

Estimates

Earnings Per Share, Policy [Policy Text Block]

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

	*For the Three Months Ended September 30,*				*For the Nine Months Ended September 30,*
	(Amounts in thousands)				(Amounts in thousands)
	*2025*		*2024*		*2025*		*2024*
Weighted average number of shares outstanding for basic per share calculation		18,072		17,868		18,031		16,707
Effect of dilutive potential shares:
Stock options		210		278		217		254
Restricted stock awards		108		109		117		104
Adjusted weighted average shares for diluted per share calculation		18,390		18,255		18,365		17,065
Anti-dilutive shares:
Stock options		—		—		—		—
Restricted stock awards		—		—		—		—

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-12

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Note 10 - Income Taxes (Details Textual)	3 Months Ended		9 Months Ended
Note 10 - Income Taxes (Details Textual)	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Effective Income Tax Rate Reconciliation, Percent	24.70%	26.10%	24.30%	26.10%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent	3.60%	0.50%

Note 5 - Acquisitions

9 Months Ended

Sep. 30, 2025

Business Combination [Text Block]

5. Acquisitions

The Company’s acquisitions have been accounted for in accordance with ASC Topic 805, Business Combinations, and the resulting goodwill and other intangible assets were accounted for under ASC Topic 350, Goodwill and Other Intangible Assets. Under business combination accounting, the assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The results of each business acquisition are included on the Unaudited Condensed Consolidated Statements of Income from the date of acquisition.

Management’s assessment of qualitative factors affecting goodwill for each acquisition includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations and the payor profile in the markets.

Helping Hands

On August 1, 2025, the Company completed the acquisition of Helping Hands Home Care Service, Inc., a Pennsylvania corporation (the “Helping Hands Acquisition”), for approximately $21.4 million. The purchase was funded through the Company’s revolving credit facility and available cash. With the Helping Hands Acquisition, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania. The related acquisition and integration costs were $0.3 million and $0.1 million for the three months ended September 30, 2025, and $0.9 million and $0.1 million for the nine months ended September 30, 2025, respectively. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

	*Total (Amounts in Thousands)*
Goodwill	$	19,022
Identifiable intangible assets		1,150
Cash		584
Accounts receivable		1,365
Property and equipment		19
Operating lease assets, net		282
Other current assets		45
Accounts payable		(98	)
Accrued payroll		(697	)
Operating lease liabilities, total		(257	)
Total purchase price	$	21,415

Identifiable intangible assets acquired included $1.2 million of definite-lived state licenses. The preliminary estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Helping Hands Acquisition accounted for $3.1 million of net service revenues and $0.4 million of operating income for each of the three and nine months ended September 30, 2025, respectively.

The following table contains unaudited pro forma condensed consolidated income statement information of the Company for the three and nine months ended September 30, 2025 as if the Helping Hands Acquisition closed on January 1, 2024.

	*For the Three Months Ended September 30,*				*For the Nine Months Ended September 30,*
	(Amounts in Thousands)				(Amounts in thousands)
	*2025*		*2024*		*2025*		*2024*
Net service revenues	$	364,001	$	293,804	$	1,060,396	$	868,481
Operating income		32,153		26,486		97,372		76,915
Net income		22,327		20,555		67,120		54,908
Net income per common share
Basic income per share	$	1.24	$	1.15	$	3.72	$	3.29
Diluted income per share	$	1.21	$	1.13	$	3.65	$	3.22

The entire disclosure for business combination.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-38

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 46
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-46

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 43
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-43

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 45
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-45

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-4

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 40
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479326/805-40-45-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-30/tableOfContent

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-20/tableOfContent

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-10/tableOfContent

Note 13 - Significant Payors - Revenue from External Customers by Products and Services (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2025

Sep. 30, 2024

Sep. 30, 2025

Sep. 30, 2024

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member]

$ 362,301

$ 289,787

$ 1,049,452

$ 857,455

$ 275,770

$ 215,433

$ 803,238

$ 636,253

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | State, Local, and Other Governmental Programs [Member]

100.00%

$ 139,383

$ 116,702

$ 410,781

$ 337,458

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Managed Care Organizations [Member]

50.50%

54.20%

51.10%

53.00%

$ 127,293

$ 93,321

$ 366,210

$ 281,732

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Commercial Insurance [Member]

46.20%

43.30%

45.60%

44.30%

$ 1,860

$ 1,415

$ 4,356

$ 4,368

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Private Pay [Member]

0.70%

0.50%

0.70%

$ 7,064

$ 3,599

$ 21,331

$ 11,194

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Other [Member]

2.50%

1.70%

2.70%

1.80%

$ 170

$ 396

$ 560

$ 1,501

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member]

0.10%

0.20%

$ 68,891

$ 57,309

$ 192,540

$ 169,202

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Medicare [Member]

100.00%

$ 64,148

$ 52,413

$ 178,784

$ 154,187

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Managed Care Organizations [Member]

93.10%

91.50%

92.90%

91.10%

$ 2,216

$ 1,821

$ 6,245

$ 5,518

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Commercial Insurance [Member]

3.20%

3.30%

$ 2,140

$ 2,892

$ 6,518

$ 8,870

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Other [Member]

3.10%

5.00%

3.40%

5.20%

$ 387

$ 183

$ 993

$ 627

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member]

0.60%

0.30%

0.50%

0.40%

$ 17,640

$ 17,045

$ 53,674

$ 52,000

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | Medicare [Member]

100.00%

$ 11,617

$ 12,036

$ 36,711

$ 36,216

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | Managed Care Organizations [Member]

65.90%

70.60%

68.40%

69.60%

$ 4,492

$ 4,215

$ 12,564

$ 13,291

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | State, Local, and Other Governmental Programs (Excluding Medicare) [Member]

25.50%

24.70%

23.40%

25.60%

$ 993

$ (17)

$ 2,878

$ 0

Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | Other [Member]

5.60%

0.00%

5.30%

0.00%

$ 538

$ 811

$ 1,521

$ 2,493

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member]

3.00%

4.70%

2.90%

4.80%

$ 275,770

$ 215,433

$ 803,238

$ 636,253

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | ILLINOIS

100.00%

$ 115,989

$ 111,916

$ 342,629

$ 330,265

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | NEW MEXICO

42.10%

51.90%

42.70%

51.90%

$ 30,029

$ 28,962

$ 87,320

$ 86,573

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | NEW YORK

10.90%

13.40%

10.90%

13.60%

^[1]

$ (318)

$ 21,406

$ (104)

$ 68,239

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | TEXAS

^[1]

0.00%

9.90%

0.00%

10.70%

$ 53,449

$ 0

$ 155,773

$ 0

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | All Other States [Member]

19.40%

0.00%

19.40%

0.00%

$ 76,621

$ 53,149

$ 217,620

$ 151,176

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member]

27.60%

24.80%

27.00%

23.80%

$ 68,891

$ 57,309

$ 192,540

$ 169,202

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | ILLINOIS

100.00%

$ 15,532

$ 13,289

$ 44,516

$ 38,544

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | OHIO

22.50%

23.20%

23.10%

22.80%

$ 26,913

$ 21,531

$ 73,304

$ 62,400

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | NEW MEXICO

39.10%

37.60%

38.10%

36.90%

$ 8,769

$ 6,951

$ 24,865

$ 21,361

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | All Other States [Member]

12.70%

12.10%

12.90%

12.60%

$ 17,677

$ 15,538

$ 49,855

$ 46,897

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member]

25.70%

27.10%

25.90%

27.70%

$ 17,640

$ 17,045

$ 53,674

$ 52,000

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | ILLINOIS

100.00%

$ 1,759

$ 2,413

$ 5,680

$ 8,397

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | NEW MEXICO

10.00%

14.20%

10.60%

16.10%

$ 8,644

$ 8,090

$ 25,937

$ 24,166

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | TENNESSEE

49.00%

47.40%

48.30%

46.50%

$ 6,852

$ 6,542

$ 21,672

$ 19,437

Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | All Other States [Member]

38.80%

38.40%

40.40%

37.40%

$ 385

$ 0

$ 385

$ 0

2.20%

0.00%

0.70%

0.00%

[1]

As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

Note 3 - Divestiture (Tables)

9 Months Ended

Sep. 30, 2025

Disposal Groups, Including Discontinued Operations [Table Text Block]

	*September 30, 2025*
Assets
Current assets
Accounts receivable, net of allowances	$	—
Prepaid expenses and other current assets		12
Total current assets		12
Property and equipment, net of accumulated depreciation and amortization		—
Other assets
Goodwill		—
Intangibles, net of accumulated amortization		—
Operating lease assets, net		2,724
Total other assets		2,724
Total assets	$	2,736
Liabilities
Current liabilities
Accounts payable	$	1,150
Accrued payroll		—
Accrued expenses		1,045
Operating lease liabilities, current portion		618
Total current liabilities		2,813
Long-term liabilities
Operating lease liabilities, long-term portion		2,043
Total liabilities	$	4,856

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-SubTopic 10
-Topic 360
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-11

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 20
-Topic 205
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-1

Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3

Note 5 - Acquisitions (Details Textual) - Helping Hands Home Care Service, Inc. [Member] - USD ($) $ in Millions		3 Months Ended	9 Months Ended
	Aug. 01, 2025	Sep. 30, 2025	Sep. 30, 2025
Business Combination, Consideration Transferred	$ 21.4
Business Combination, Acquisition-Related Cost, Expense		$ 0.3	$ 0.9
Business Combination, Integration-Related Cost, Expense		0.1	0.1
Business Combination, Acquiree's Revenue since Acquisition Date, Actual		3.1	3.1
Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual		$ 0.4	$ 0.4
State Licenses [Member]
Finite-Lived Intangible Assets Acquired	$ 1.2

Note 7 - Details of Certain Balance Sheet Accounts

9 Months Ended

Sep. 30, 2025

Supplemental Balance Sheet Disclosures [Text Block]

7. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

	*September 30, 2025*		*December 31, 2024*
	(Amounts in Thousands)
Income tax receivable	$	2,255	$	11,568
Prepaid payroll		5,506		8,716
Prepaid workers' compensation and liability insurance		5,323		4,254
Prepaid licensing fees		4,874		5,414
Workers' compensation insurance receivable		804		810
Other ⁽¹⁾		5,931		7,829
Total prepaid expenses and other current assets	$	24,693	$	38,591

(1)

Included $2.3 million and $6.1 million related to the New York Asset Sale deferred payments as of September 30, 2025 and December 31, 2024, respectively.

Accrued expenses consisted of the following:

	*September 30, 2025*		*December 31, 2024*
	(Amounts in Thousands)
Accrued health benefits	$	6,602	$	6,637
Accrued professional fees		6,151		5,368
Accrued payroll and other taxes		5,681		4,516
Other		14,508		12,438
Total accrued expenses	$	32,942	$	28,959

Note 4 - Leases - Schedule of Cash Flow, Supplemental Disclosures (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating cash flows from operating leases	$ 12,505	$ 10,925
Operating leases	$ 7,156	$ 7,683

Note 7 - Details of Certain Balance Sheet Accounts - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Accrued health benefits	$ 6,602	$ 6,637
Accrued professional fees	6,151	5,368
Accrued payroll and other taxes	5,681	4,516
Other	14,508	12,438
Total accrued expenses	$ 32,942	$ 28,959

Note 4 - Leases - Schedule of Operating Lease Liability Maturities (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
2026	$ 15,759
2027	12,614
2028	9,143
2029	6,946
2030	6,016
Thereafter	11,064
Total future minimum rental commitments	61,542
Less: Imputed interest	(9,697)
Total lease liabilities	$ 51,845	$ 54,683

Note 6 - Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2025
Goodwill, Balance		$ 970,558
Additions for acquisitions		22,407
Adjustments to previously recorded goodwill	$ (300)	(4,412)
Goodwill, Balance	988,553	988,553
Hospice Segment [Member]
Goodwill, Balance		432,840
Additions for acquisitions		0
Adjustments to previously recorded goodwill		26
Goodwill, Balance	432,866	432,866
Personal Care Segment [Member]
Goodwill, Balance		442,526
Additions for acquisitions		22,407
Adjustments to previously recorded goodwill		(4,096)
Goodwill, Balance	460,837	460,837
Home Health Segment [Member]
Goodwill, Balance		95,192
Additions for acquisitions		0
Adjustments to previously recorded goodwill		(342)
Goodwill, Balance	$ 94,850	$ 94,850

Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-41

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 740
-Name Accounting Standards Codification
-Section 55
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478064/805-740-55-13

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 39
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-39

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482598/350-20-45-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Note 12 - Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2025

Sep. 30, 2024

Sep. 30, 2025

Sep. 30, 2024

$ 362,301

$ 289,787

$ 1,049,452

$ 857,455

Depreciation and amortization

32,937

25,953

96,338

75,779

4,408

3,446

12,264

10,316

Interest income

(760)

(1,908)

(1,845)

(2,805)

Interest expense

3,343

573

10,886

5,445

Operating Segments [Member]

362,301

289,787

1,049,452

857,455

17,926

^[1]

16,046

^[1]

51,865

^[2]

47,568

^[2]

Other general and administrative expenses

72,452

56,307

208,517

169,210

35,107

26,908

99,915

83,115

Depreciation and amortization

4,408

3,446

12,264

10,316

Interest income

(760)

(1,908)

(1,845)

(2,805)

Interest expense

3,343

573

10,886

5,445

Income before income taxes

30,354

27,288

87,297

73,139

Operating Segments [Member] | Cost of Sales [Member]

Operating Segments [Member] | General and Administrative Expense [Member]

238,098

191,376

689,863

564,134

Operating Segments [Member] | Personal Care [Member]

33,825

26,058

99,207

76,543

275,770

215,433

803,238

636,253

6,395

^[1]

5,741

^[1]

18,468

^[2]

15,835

^[2]

Operating Segments [Member] | Personal Care [Member] | Cost of Sales [Member]

51,090

41,671

150,320

124,782

Operating Segments [Member] | Personal Care [Member] | General and Administrative Expense [Member]

199,656

156,072

579,174

460,587

Operating Segments [Member] | Hospice [Member]

18,629

11,949

55,276

35,049

68,891

57,309

192,540

169,202

10,131

^[1]

9,192

^[1]

29,531

^[2]

27,960

^[2]

Operating Segments [Member] | Hospice [Member] | Cost of Sales [Member]

18,815

12,770

48,254

39,061

Operating Segments [Member] | Hospice [Member] | General and Administrative Expense [Member]

28,287

24,791

80,670

71,580

Operating Segments [Member] | Home Health [Member]

11,658

10,556

34,085

30,601

17,640

17,045

53,674

52,000

1,400

^[1]

1,113

^[1]

3,866

^[2]

3,773

^[2]

Operating Segments [Member] | Home Health [Member] | Cost of Sales [Member]

2,547

1,866

9,943

5,367

Operating Segments [Member] | Home Health [Member] | General and Administrative Expense [Member]

10,155

10,513

30,019

31,967

Prepaid workers' compensation and liability insurance

$ 3,538

$ 3,553

$ 9,846

$ 10,893

[1]	Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.
[2]	Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

Note 7 - Details of Certain Balance Sheet Accounts - Schedule of Other Current Assets (Details) - USD ($)
$ in Thousands

Sep. 30, 2025

Dec. 31, 2024

Income tax receivable

$ 2,255

$ 11,568

Prepaid payroll

5,506

8,716

5,323

4,254

Prepaid licensing fees

4,874

5,414

Workers' compensation insurance receivable

804

810

Other (1)

^[1]

5,931

7,829

Total prepaid expenses and other current assets

$ 24,693

$ 38,591

[1]	Included $2.3 million and $6.1 million related to the New York Asset Sale deferred payments as of September 30, 2025 and December 31, 2024, respectively.

Note 14 - Subsequent Events

9 Months Ended

Sep. 30, 2025

Subsequent Events [Text Block]

14. Subsequent Events

On October 1, 2025, the Company completed the acquisition of the assets of Gold Horses, LLC for approximately $7.4 million (the “Gold Horses Acquisition”). The purchase was funded through the Company’s available cash. The Gold Horses Acquisition expanded the Company’s services within its personal care segment in Texas. The initial accounting is not yet complete, and therefore the related business combination disclosures have not been presented as the Company is currently in the process of valuing the assets acquired and liabilities assumed in the transaction.

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2023	16,227
Balance at Dec. 31, 2023	$ 16	$ 403,846	$ 302,832	$ 706,694
Issuance of shares of common stock under restricted stock award agreements (in shares)	151
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(5)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	8,307	0	8,307
Shares issued for exercise of stock options (in shares)	35
Shares issued for exercise of stock options	$ 0	2,983	0	2,983
Net income	$ 0	0	54,072	54,072
Balance (in shares) at Sep. 30, 2024	18,133
Balance at Sep. 30, 2024	$ 18	590,712	356,904	947,634
Shares issued in Public offering, net of offering costs (in shares)	1,725
Shares issued in Public offering, net of offering costs	$ 2	175,576	0	175,578
Balance (in shares) at Jun. 30, 2024	18,100
Balance at Jun. 30, 2024	$ 18	584,896	336,741	921,655
Issuance of shares of common stock under restricted stock award agreements (in shares)	0
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(2)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	2,833	0	2,833
Shares issued for exercise of stock options (in shares)	35
Shares issued for exercise of stock options	$ 0	2,983	0	2,983
Net income	$ 0	0	20,163	20,163
Balance (in shares) at Sep. 30, 2024	18,133
Balance at Sep. 30, 2024	$ 18	590,712	356,904	947,634
Shares issued in Public offering, net of offering costs (in shares)	0
Shares issued in Public offering, net of offering costs	$ 0	0	0	0
Balance (in shares) at Dec. 31, 2024	18,148
Balance at Dec. 31, 2024	$ 18	594,044	376,430	970,492
Issuance of shares of common stock under restricted stock award agreements (in shares)	265
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(5)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	11,877	0	11,877
Shares issued for exercise of stock options (in shares)	75
Shares issued for exercise of stock options	$ 0	1,477	0	1,477
Net income	$ 0	0	66,128	66,128
Balance (in shares) at Sep. 30, 2025	18,483
Balance at Sep. 30, 2025	$ 18	607,398	442,558	1,049,974
Balance (in shares) at Jun. 30, 2025	18,407
Balance at Jun. 30, 2025	$ 18	602,126	419,710	1,021,854
Issuance of shares of common stock under restricted stock award agreements (in shares)	28
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(2)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	4,287	0	4,287
Shares issued for exercise of stock options (in shares)	50
Shares issued for exercise of stock options	$ 0	985	0	985
Net income	$ 0	0	22,848	22,848
Balance (in shares) at Sep. 30, 2025	18,483
Balance at Sep. 30, 2025	$ 18	$ 607,398	$ 442,558	$ 1,049,974

Note 1 - Nature of Operations, Consolidation, and Presentation of Financial Statements (Details Textual)	9 Months Ended
	Sep. 30, 2025
Number of Operating Segments	3
Number of Reportable Segments	3

Note 1 - Nature of Operations, Consolidation, and Presentation of Financial Statements

9 Months Ended

Sep. 30, 2025

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2024 has been derived from the Company’s audited financial statements for the year ended December 31, 2024 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2024 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Note 12 - Segment Information

9 Months Ended

Sep. 30, 2025

Segment Reporting Disclosure [Text Block]

12. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s CODM. The Company identifies its Chief Executive Officer and Chief Operating Officer together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

The CODMs do not review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.

	*For the Three Months Ended September 30, 2025*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	275,770	$	68,891	$	17,640	$	362,301
Direct service personnel		199,656		28,287		10,155		238,098
General and administrative salaries, wages and benefits		18,629		11,658		3,538		33,825
Other segment items ¹		6,395		10,131		1,400		17,926
Segment operating income		51,090		18,815		2,547		72,452
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								35,107
Depreciation and amortization								4,408
Interest income								(760	)
Interest expense								3,343
Income before income taxes							$	30,354

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

	*For the Three Months Ended September 30, 2024*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	215,433	$	57,309	$	17,045	$	289,787
Direct service personnel		156,072		24,791		10,513		191,376
General and administrative salaries, wages and benefits		11,949		10,556		3,553		26,058
Other segment items ¹		5,741		9,192		1,113		16,046
Segment operating income		41,671		12,770		1,866		56,307
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								26,908
Depreciation and amortization								3,446
Interest income								(1,908	)
Interest expense								573
Income before income taxes							$	27,288

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

	*For the Nine Months Ended September 30, 2025*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	803,238	$	192,540	$	53,674	$	1,049,452
Direct service personnel		579,174		80,670		30,019		689,863
General and administrative salaries, wages and benefits		55,276		34,085		9,846		99,207
Other segment items ¹		18,468		29,531		3,866		51,865
Segment operating income		150,320		48,254		9,943		208,517
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								99,915
Depreciation and amortization								12,264
Interest income								(1,845	)
Interest expense								10,886
Income before income taxes							$	87,297

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

	*For the Nine Months Ended September 30, 2024*
	(Amounts in Thousands)
	*Personal Care*		*Hospice*		*Home Health*		*Total*
Net service revenues	$	636,253	$	169,202	$	52,000	$	857,455
Direct service personnel		460,587		71,580		31,967		564,134
General and administrative salaries, wages and benefits		35,049		30,601		10,893		76,543
Other segment items ¹		15,835		27,960		3,773		47,568
Segment operating income		124,782		39,061		5,367		169,210
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								83,115
Depreciation and amortization								10,316
Interest income								(2,805	)
Interest expense								5,445
Income before income taxes							$	73,139

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Note 3 - Divestiture

9 Months Ended

Sep. 30, 2025

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

3. Divestiture

Effective May 20, 2024, the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 50% cash consideration, paid out as an initial payment of $4.6 million and $6.9 million paid pro rata as a deferred payment as caregivers are transferred, and 50% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business. The Company entered into a consulting agreement with the purchaser effective May 20, 2024, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. The Company determined that the consulting agreement gave it the ability to control the business until October 2024, when the Company determined that it no longer controlled the business as it transferred more than 50% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $3.7 million during the year ended December 31, 2024. The gain was reflected within general and administrative expenses on the consolidated statement of operations.

In connection with this transaction, the Company ceased operations in New York. During the nine months ended September 30, 2025, the Company recorded deferred payments of $3.8 million with the remaining $2.3 million due from the purchaser reflected within prepaid expenses and other current assets on the condensed consolidated balance sheets as of September 30, 2025. No amount was recorded related to the CDPAP business contingent consideration.

The New York Asset Sale did not qualify as a discontinued operation because it did not represent a strategic shift that has or will have a major effect on the Company’s operation or financial results.

Goodwill and intangible assets of $2.9 million and $4.2 million, respectively, were derecognized in connection with the divestiture. The carrying amounts of the assets and liabilities associated with the New York personal care operations included in our Consolidated Balance Sheets as of September 30, 2025 were as follows (amounts in thousands):

	*September 30, 2025*
Assets
Current assets
Accounts receivable, net of allowances	$	—
Prepaid expenses and other current assets		12
Total current assets		12
Property and equipment, net of accumulated depreciation and amortization		—
Other assets
Goodwill		—
Intangibles, net of accumulated amortization		—
Operating lease assets, net		2,724
Total other assets		2,724
Total assets	$	2,736
Liabilities
Current liabilities
Accounts payable	$	1,150
Accrued payroll		—
Accrued expenses		1,045
Operating lease liabilities, current portion		618
Total current liabilities		2,813
Long-term liabilities
Operating lease liabilities, long-term portion		2,043
Total liabilities	$	4,856

Note 3 - Divestiture - Schedule of Discontinued Operations (Details) - New York Personal Care Operations [Member] $ in Thousands	Sep. 30, 2025 USD ($)
Accounts receivable, net of allowances	$ 0
Prepaid expenses and other current assets	12
Total current assets	12
Property and equipment, net of accumulated depreciation and amortization	0
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent	0
Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent	0
Operating lease assets, net	2,724
Total other assets	2,724
Total assets	2,736
Accounts payable	1,150
Accrued payroll	0
Accrued expenses	1,045
Operating lease liabilities, current portion	618
Total current liabilities	2,813
Operating lease liabilities, long-term portion	2,043
Total liabilities	$ 4,856

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Net service revenues	$ 362,301	$ 289,787	$ 1,049,452	$ 857,455
Cost of service revenues	245,586	197,583	711,183	583,916
Gross profit	116,715	92,204	338,269	273,539
General and administrative expenses	79,370	62,805	229,667	187,444
Depreciation and amortization	4,408	3,446	12,264	10,316
Total operating expenses	83,778	66,251	241,931	197,760
Operating income	32,937	25,953	96,338	75,779
Interest income	(760)	(1,908)	(1,845)	(2,805)
Interest expense	3,343	573	10,886	5,445
Total interest expense, net	2,583	(1,335)	9,041	2,640
Income before income taxes	30,354	27,288	87,297	73,139
Income tax expense	7,506	7,125	21,169	19,067
Net income	$ 22,848	$ 20,163	$ 66,128	$ 54,072
Net income per common share
Basic income per share (in dollars per share)	$ 1.26	$ 1.13	$ 3.67	$ 3.24
Diluted income per share (in dollars per share)	$ 1.24	$ 1.1	$ 3.6	$ 3.17
Weighted average number of common shares and potential common shares outstanding:
Basic (in shares)	18,072	17,868	18,031	16,707
Diluted (in shares)	18,390	18,255	18,365	17,065

Note 2 - Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Weighted Average Number of Shares [Table Text Block]

	*For the Three Months Ended September 30,*				*For the Nine Months Ended September 30,*
	(Amounts in thousands)				(Amounts in thousands)
	*2025*		*2024*		*2025*		*2024*
Weighted average number of shares outstanding for basic per share calculation		18,072		17,868		18,031		16,707
Effect of dilutive potential shares:
Stock options		210		278		217		254
Restricted stock awards		108		109		117		104
Adjusted weighted average shares for diluted per share calculation		18,390		18,255		18,365		17,065
Anti-dilutive shares:
Stock options		—		—		—		—
Restricted stock awards		—		—		—		—

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2025	Oct. 28, 2025
Document Information [Line Items]
Entity Central Index Key	0001468328
Entity Registrant Name	Addus HomeCare Corp
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2025
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2025
Document Transition Report	false
Entity File Number	001-34504
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way, Suite 600
Entity Address, City or Town	Frisco
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75034
City Area Code	469
Local Phone Number	535-8200
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	ADUS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		18,483,271

Note 6 - Goodwill and Intangible Assets

9 Months Ended

Sep. 30, 2025

Goodwill and Intangible Assets Disclosure [Text Block]

6. Goodwill and Intangible Assets

A summary of the goodwill by segment and related adjustments is provided below:

						*Home*
	*Hospice*		*Personal Care*			*Health*			*Total*
	(Amounts in Thousands)
Goodwill as of December 31, 2024	$	432,840	$	442,526		$	95,192		$	970,558
Additions for acquisitions		—		22,407			—			22,407
Adjustments to previously recorded goodwill		26		(4,096	)		(342	)		(4,412	)
Goodwill as of September 30, 2025	$	432,866	$	460,837		$	94,850		$	988,553

On January 1, 2025, the Company completed its acquisition of its Jacksonville affiliate for approximately $0.8 million (the “Jacksonville Acquisition”), with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC for $2.6 million (the “Great Lakes Acquisition”), with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

In connection with the Helping Hands Acquisition, the Company recognized goodwill in its personal care segment of $19.1 million during the nine months ended September 30, 2025.

During the three and nine months ended September 30, 2025, the Company recorded $0.3 million and $4.4 million, respectively, related to measurement period adjustments to previously recorded goodwill including $2.9 million of proceeds received in connection with the Gentiva Acquisition.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from three to fifteen years.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:

		*September 30, 2025*							*December 31, 2024*
		(Amounts in Thousands)							(Amounts in Thousands)
	*Estimated Useful*	*Gross*		*Accumulated*			*Net*		*Gross*		*Accumulated*			*Net*
	*Life (years)*	*carrying value*		*amortization*			*carrying value*		*carrying value*		*amortization*			*carrying value*
Customer and referral relationships	3 - 15	$	34,201	$	(33,559	)	$	642	$	34,201	$	(33,255	)	$	946
Trade names and trademarks	1 - 20		59,366		(25,376	)		33,990		59,366		(21,900	)		37,466
Non-competition agreement	3 - 5		6,728		(6,582	)		146		6,728		(6,263	)		465
State Licenses	6 - 10		26,529		(3,536	)		22,993		24,981		(1,243	)		23,738
State Licenses	Indefinite		46,630		—			46,630		47,028		—			47,028
Total intangible assets		$	173,454	$	(69,053	)	$	104,401	$	172,304	$	(62,661	)	$	109,643

In connection with the Helping Hands Acquisition, the Company recognized state licenses of $1.2 million in its personal care segment during the nine months ended September 30, 2025.

Amortization expense related to the intangible assets was $2.4 million and $6.4 million for the three and nine months ended September 30, 2025, respectively, and $1.8 million and $5.4 million for the three and nine months ended September 30, 2024, respectively. The weighted average remaining useful lives of identifiable intangible assets as of September 30, 2025 was 9.28 years.

Note 6 - Goodwill and Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Goodwill [Table Text Block]

						*Home*
	*Hospice*		*Personal Care*			*Health*			*Total*
	(Amounts in Thousands)
Goodwill as of December 31, 2024	$	432,840	$	442,526		$	95,192		$	970,558
Additions for acquisitions		—		22,407			—			22,407
Adjustments to previously recorded goodwill		26		(4,096	)		(342	)		(4,412	)
Goodwill as of September 30, 2025	$	432,866	$	460,837		$	94,850		$	988,553

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		*September 30, 2025*							*December 31, 2024*
		(Amounts in Thousands)							(Amounts in Thousands)
	*Estimated Useful*	*Gross*		*Accumulated*			*Net*		*Gross*		*Accumulated*			*Net*
	*Life (years)*	*carrying value*		*amortization*			*carrying value*		*carrying value*		*amortization*			*carrying value*
Customer and referral relationships	3 - 15	$	34,201	$	(33,559	)	$	642	$	34,201	$	(33,255	)	$	946
Trade names and trademarks	1 - 20		59,366		(25,376	)		33,990		59,366		(21,900	)		37,466
Non-competition agreement	3 - 5		6,728		(6,582	)		146		6,728		(6,263	)		465
State Licenses	6 - 10		26,529		(3,536	)		22,993		24,981		(1,243	)		23,738
State Licenses	Indefinite		46,630		—			46,630		47,028		—			47,028
Total intangible assets		$	173,454	$	(69,053	)	$	104,401	$	172,304	$	(62,661	)	$	109,643

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

Note 8 - ARPA Spending Plans

9 Months Ended

Sep. 30, 2025